{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:26:03Z","timestamp":1785878763808,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jsbmb.2009.11.003","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T05:11:19Z","timestamp":1258175479000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: Insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens"],"prefix":"10.1016","volume":"118","author":[{"given":"Ken C.N.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.N.","family":"Bodine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Komm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.jsbmb.2009.11.003_bib1","first-page":"SU385","article-title":"Bazedoxifene_conjugated estrogens: a balanced combination to provide optimal \u201cestrogenic\u201d safety and efficacy","volume":"18","author":"Komm","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib2","series-title":"Osteoporosis","first-page":"305","article-title":"Regulation of bone cell function by estrogens","author":"Komm","year":"2001"},{"issue":"9","key":"10.1016\/j.jsbmb.2009.11.003_bib3","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","article-title":"Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity","volume":"146","author":"Komm","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2009.11.003_bib4","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1210\/endo-118-6-2411","article-title":"Estrogen regulation of protein synthesis in the immature rat uterus: the analysis of proteins released into the medium during in vitro incubation","volume":"118","author":"Komm","year":"1986","journal-title":"Endocrinology"},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2009.11.003_bib5","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.bone.2008.07.257","article-title":"Efficacy and safety of bazedoxifene in postmenopausal Asian women","volume":"43","author":"Xu","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jsbmb.2009.11.003_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2009.05.093","article-title":"Bazedoxifene\/conjugated estrogens (BZA\/CE): incidence of uterine bleeding in postmenopausal women","volume":"92","author":"Archer","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue-selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib10","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effects of raloxifene on risk of breastcancer in postmenopausal women: results from the MORE randomized trial","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2009.11.003_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ygyno.2003.10.038","article-title":"Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma","volume":"92","author":"Ferguson","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1971.33","article-title":"A new anti-oestrogenic agent in late breast cancer: an early clinical appraisal of ICI46474","volume":"25","author":"Cole","year":"1971","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2009.11.003_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(24)01358-9","article-title":"Basic guide to the mechanisms of antiestrogen action","volume":"50","author":"MacGregor","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib14","first-page":"855","article-title":"Tamoxifen treatment and gynecologic side effects: a review","volume":"97","author":"Mourits","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.1997.15.2.840","article-title":"Clinical potential of new antiestrogens","volume":"15","author":"Gradishar","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000226637","article-title":"Phase II evaluation of Ly156758 in metastatic breast cancer","volume":"45","author":"Buzdar","year":"1988","journal-title":"Oncology"},{"key":"10.1016\/j.jsbmb.2009.11.003_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats","volume":"93","author":"Black","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 2","key":"10.1016\/j.jsbmb.2009.11.003_bib18","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/BF02383389","article-title":"Raloxifene: a selective estrogen receptor modulator","volume":"12","author":"Sato","year":"1994","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.11.003_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Connor","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.jsbmb.2009.11.003_bib20","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1016\/j.bone.2009.03.108","article-title":"The response of bone turnover markers to lasofoxifene: The PEARL trial","volume":"44","author":"Eastell","year":"2009","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.jsbmb.2009.11.003_bib21","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/en.2003-0567","article-title":"Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype","volume":"144","author":"Frasor","year":"2003","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jsbmb.2009.11.003_bib22","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1158\/0008-5472.CAN-03-3326","article-title":"Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells","volume":"64","author":"Frasor","year":"2004","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.jsbmb.2009.11.003_bib23","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1158\/0008-5472.CAN-05-4269","article-title":"Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome","volume":"66","author":"Frasor","year":"2006","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.11.003_bib24","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/me.2006-0474","article-title":"Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation","volume":"21","author":"Stender","year":"2007","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.11.003_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/me.2008-0366","article-title":"Differential biochemical and cellular actions of premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination","volume":"23","author":"Berrodin","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib26","first-page":"4419","article-title":"Gene expression profiles with activation of the estrogen receptor \u03b1-selective estrogen receptor modulator complex in breast cancer cell expressing wild-type estrogen receptor","volume":"62","author":"Levenson","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2008.09.022","article-title":"Differential estradiol and selective estrogen receptor modulator (SERM) regulation of keratin 13 gene expression and its underlying mechanism in breast cancer cells","volume":"296","author":"Sheng","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0300001","article-title":"Comparison of the effect of oestradiol, tamoxifen and raloxifene on nerve growth factor-\u03b1 expression in specific neonatal mouse uterine cell types using laser capture microdissection","volume":"30","author":"Green","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib29","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1068537","article-title":"Molecular determinants for the tissue specificity of SERMs","volume":"295","author":"Shang","year":"2002","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jsbmb.2009.11.003_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/molehr\/gap045","article-title":"Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells","volume":"15","author":"Flamini","year":"2009","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","article-title":"Fox A1 translates epigenetic signatures into enhancer-driven lineage-specific transcription","volume":"132","author":"Lupien","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2009.11.003_bib32","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1101\/gad.1446006","article-title":"A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer","volume":"20","author":"Eeckhoute","year":"2006","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.11.003_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/nar\/gkm945","article-title":"Mechanism of primary and secondary estrogen target gene regulation in breast cancer cells","volume":"36","author":"Bourdeau","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.11.003_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1541-7786.MCR-04-0122","article-title":"Letrozole-, anastrozole- and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach","volume":"3","author":"Itoh","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib35","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1210\/me.2005-0334","article-title":"Estrogen receptor target gene: an evolving concept","volume":"8","author":"Carroll","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2009.11.003_bib36","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ng1901","article-title":"Genome-wide analysis of estrogen receptor binding sites","volume":"38","author":"Carroll","year":"2006","journal-title":"Nat. Genet."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007600900274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007600900274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:33:52Z","timestamp":1760744032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007600900274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S096007600900274X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.11.003","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: Insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}